Aquestive Therapeutics Inc.
AQST | NASDAQ
$4.78
+$0.17 (+3.69%)
At close: Sep 21, 2026, 4:00 PM ET
$4.74
-$0.04 (-0.84%)
After-hours:
Sep 21, 2026, 7:59 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 13.82M | 14.45M | 13.02M | 12.81M | 10M | 8.72M | 11.87M | 13.54M | 20.1M | 12.05M | 13.21M | 13M | 13.24M | 11.13M | 10.68M | 11.46M | 13.27M | 12.27M | 11.08M | 13.29M | 15.35M | 11.12M |
Cost of Revenue | 4.02M | 3.47M | 5.84M | 4.51M | 4.56M | 3.65M | 4.52M | 4.44M | 4.53M | 4.39M | 4.68M | 4.8M | 6.62M | 4.74M | 5.31M | 4.63M | 5.24M | 4.21M | 3.37M | 4.4M | 4.47M | 2.76M |
Gross Profit | 9.8M | 10.98M | 7.18M | 8.3M | 5.44M | 5.07M | 7.35M | 9.11M | 15.57M | 7.66M | 8.53M | 8.2M | 6.62M | 6.4M | 5.38M | 6.84M | 8.02M | 8.06M | 7.71M | 8.89M | 10.88M | 8.37M |
Operating Income | -8.22M | -4.2M | -28.84M | -11.48M | -11.37M | -19.37M | -13.58M | -8.29M | 55K | -8.96M | -3.91M | -2.38M | -4.21M | -4.61M | -10.71M | -8.85M | -12.76M | -9.74M | -11.67M | -7.97M | -6.52M | -8.53M |
Interest Income | 882K | n/a | n/a | n/a | n/a | n/a | 734K | 979K | 1.4M | 329K | 165K | 1.51M | 129K | 14.51M | 65K | 5K | 32K | n/a | 135K | n/a | 373K | n/a |
Pretax Income | -22.86M | -8.06M | -31.86M | -15.45M | -13.55M | -22.93M | -17.07M | -11.51M | -2.75M | -12.83M | -8.01M | -2.18M | -5.51M | 8.07M | -12.35M | -12.54M | -16.3M | -13.22M | -28.95M | -14.56M | -12.37M | -14.67M |
Net Income | -22.86M | -8.06M | -31.86M | -15.45M | -13.55M | -22.93M | -17.06M | -11.51M | -2.75M | -12.83M | -8.11M | -2.04M | -5.79M | 8.07M | -12.35M | -12.54M | -16.3M | -13.22M | -28.95M | -14.56M | -12.37M | -14.67M |
Selling & General & Admin | 14.06M | 10.98M | 32.82M | 15.25M | 12.71M | 19.07M | 16.01M | 12.13M | 11.36M | 10.69M | 9.55M | 7.39M | 7.36M | 7.46M | 11.81M | 12.46M | 15.59M | 13.02M | 14.98M | 12.13M | 13.13M | 13.23M |
Research & Development | 3.96M | 4.2M | 3.2M | 4.53M | 4.11M | 5.36M | 4.92M | 5.27M | 4.16M | 5.93M | 2.89M | 3.2M | 3.47M | 3.55M | 4.28M | 3.23M | 5.2M | 4.77M | 4.4M | 4.73M | 4.26M | 3.66M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 18.03M | 15.18M | 36.02M | 19.78M | 16.81M | 24.43M | 20.93M | 17.4M | 15.52M | 16.62M | 12.44M | 10.58M | 10.83M | 11M | 16.09M | 15.69M | 20.79M | 17.79M | 19.38M | 16.86M | 17.4M | 16.89M |
Interest Expense | 3.84M | 3.94M | 4.27M | 4.27M | 4.28M | 4.28M | 4.22M | 4.2M | 4.2M | 4.2M | 3.24M | 1.31M | 1.43M | 1.49M | 1.7M | 3.69M | 3.57M | 3.48M | 3.59M | 6.59M | 6.22M | 6.15M |
Selling & Marketing Expenses | 2.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 22.04M | 18.65M | 41.85M | 24.29M | 21.37M | 28.09M | 25.45M | 21.83M | 20.04M | 21.01M | 17.12M | 15.38M | 17.45M | 15.74M | 21.4M | 20.32M | 26.03M | 22.01M | 22.75M | 21.26M | 21.86M | 19.65M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -14K | n/a | n/a | n/a | 101K | -140K | 284K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 124.99M | 122.61M | 121.97M | 110.58M | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M | 55.63M | 54.39M | 53.42M | 45.28M | 41.31M | 40.39M | 39.22M | 37.07M | 35.56M |
Shares Outstanding (Diluted) | 124.99M | 122.61M | 121.97M | 110.58M | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M | 73.79M | 54.39M | 53.42M | 45.46M | 41.47M | 40.39M | 39.22M | 37.07M | 35.56M |
EPS (Basic) | -0.18 | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 | -0.12 | -0.03 | -0.10 | 0.35 | -0.33 | -0.23 | -0.44 | -0.40 | -0.72 | -0.37 | -0.33 | -0.41 |
EPS (Diluted) | -0.18 | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 | -0.12 | -0.03 | -0.10 | 0.26 | -0.33 | -0.23 | -0.44 | -0.40 | -0.72 | -0.37 | -0.33 | -0.41 |
EBITDA | -18.78M | -4M | -27.46M | -11.03M | -9.13M | -18.51M | -12.7M | -7.15M | 1.66M | -8.42M | -4.31M | -606K | -3.79M | 9.88M | -10.25M | -8.25M | -12.06M | -9.01M | -24.63M | -7.23M | -5.4M | -7.77M |
EBIT | -19.02M | -4.12M | -27.59M | -11.17M | -9.27M | -18.65M | -12.85M | -7.31M | 1.45M | -8.63M | -4.78M | -863K | -4.08M | 9.56M | -10.65M | -8.85M | -12.73M | -9.74M | -25.36M | -7.97M | -6.14M | -8.53M |
Depreciation & Amortization | 249K | 119K | 130K | 139K | 140K | 139K | 147K | 159K | 205K | 207K | 467K | 257K | 289K | 325K | 397K | 596K | 667K | 727K | 731K | 736K | 740K | 755K |
Add to Watchlist
Select watchlists to add or remove AQST